NCT00219817View on ClinicalTrials.gov

Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Cancer Cachexia
Interventions
DRUG

RC-1291 HCl

Trial Locations (7)

10032

Columbia University Medical Center, New York

24211

Cancer Outreach Associates, Abingdon

77030

Michael E. DeBakey Veterans Affairs Medical Center, Houston

77555

University of Texas Medical Branch at Galveston, Galveston

94904

California Cancer Care Center, Greenbrae

02114

Massachusetts General Hospital, Boston

05401

Fletcher Allen Health Care, Burlington

All Listed Sponsors
lead

Helsinn Therapeutics (U.S.), Inc

INDUSTRY

NCT00219817 - Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss | Biotech Hunter | Biotech Hunter